ExodusPoint Capital Management’s Ambrx Biopharma Inc AMAM Stock Holding History

ExodusPoint Capital Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-140,842	Closed	-$2.01M	–	2082
2023 Q4	$2.01M	Sell	140,842 -352,551	-71%	-$4.01M	0.01%	576
2023 Q3	$5.67M	Buy	493,393 +15,835	+3%	+$216K	0.05%	345
2023 Q2	$7.86M	Buy	477,558 +458,061	+2,349%	+$5.76M	0.06%	305
2023 Q1	$174K	Buy	+19,497	New	+$98K	﹤0.01%	1590

ExodusPoint Capital Management's AMAM Position: Q1 2024 in Review

ExodusPoint Capital Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 140,842 shares — an estimated $2.01M sold.

ExodusPoint Capital Management first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $7.86M in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

ExodusPoint Capital Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 140,842 Ambrx Biopharma Inc shares in Q1 2024, an estimated $2.01M.
ExodusPoint Capital Management first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
ExodusPoint Capital Management's Ambrx Biopharma Inc position peaked at $7.86M in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on ExodusPoint Capital Management's 13F filing for Q1 2024, filed 14 May 2024.